Eli Lilly Shares Surge on Raised Sales Forecast
Published . Updated .
Eli Lilly & Co. raised its full-year sales forecast as demand for its blockbuster obesity and diabetes drugs continues to surge. Speaking on "Bloomberg Open Interest," Bloomberg's Madison Muller also discusses the implications for Novo Nordisk.
Directly affected
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Eli Lilly and belongs to, so it often moves with news about it.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+11.4% 30d
AbbVie is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.2% 18d
Merck is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+3.1% 30d
Abbott Laboratories is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- PFE Pfizer+8.9% 30d
Pfizer is a peer of Eli Lilly and in pharmaceutical preparations; rivals often move on the same news.
- NVS Novartis AG+1.3% 17d
Novartis AG is a peer of Novo Nordisk A/S in pharmaceutical preparations; rivals often move on the same news.
- AZN AstraZeneca+11.1% 30d
AstraZeneca is a peer of Novo Nordisk A/S in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| LLY | +1.25% | -0.87% | base | +6.41% | +9.64% | after close | after close |
| NVONo price data for this ticker | — | — | — | — | — | — | — |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
| PFENo price data for this ticker | — | — | — | — | — | — | — |
| NVSNo price data for this ticker | — | — | — | — | — | — | — |
| AZNNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Eli Lilly Shares Surge on Raised Sales Forecast Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| LLY | that day | +6.41% | final price |
| LLY | the next day | +9.64% | final price |
| LLY | three days earlier | -0.87% | final price |
| LLY | five days earlier | +1.25% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 10 Sep 2026. That is 49 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 31 Aug 2026. That is 59 days before publication. Filed 25 Sep 2026. View the filing.
- Rep. Scott Scott Franklin bought Novo Nordisk A S (NVO), worth $1,001 - $15,000 on 26 Aug 2026. That is 64 days before publication. Filed 17 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 34 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 51 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 45 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 55 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought AbbVie (ABBV), worth $50,001 - $100,000 on 31 Jul 2026. That is 90 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 35 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 71 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
How solid “Eli Lilly Shares Surge on Raised Sales Forecast” looks
12 out of 100
“Eli Lilly Shares Surge on Raised Sales Forecast” scores 12 out of 100. The score uses 1 sources.